These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
949 related articles for article (PubMed ID: 26045817)
1. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma. Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817 [TBL] [Abstract][Full Text] [Related]
2. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma. Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964 [TBL] [Abstract][Full Text] [Related]
3. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma. Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228 [TBL] [Abstract][Full Text] [Related]
4. Rho/ROCK Pathway Regulates Migration and Invasion of Esophageal Squamous Cell Carcinoma by Regulating Caveolin-1. Liu Z; Yu J; Wu R; Tang S; Cai X; Guo G; Chen S Med Sci Monit; 2017 Dec; 23():6174-6185. PubMed ID: 29288243 [TBL] [Abstract][Full Text] [Related]
5. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation. Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305 [TBL] [Abstract][Full Text] [Related]
6. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma. Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458 [TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo]. Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma. Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma. He Z; Yi J; Jin L; Pan B; Chen L; Song H Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma. Wei R; Shang Z; Leng J; Cui L J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242 [TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma. Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043 [TBL] [Abstract][Full Text] [Related]
12. [Expression of IGF-1R in esophageal squamous cell carcinoma and the effect of its silencing by siRNA on the proliferation of esophageal cancer EC9706 cells in vitro]. Ma W; Li W; Fan QX; Wang LX; Wang RL; Lu SX Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):609-12. PubMed ID: 22325222 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro. Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048 [TBL] [Abstract][Full Text] [Related]
14. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients]. Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836 [No Abstract] [Full Text] [Related]
15. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma]. Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013 [TBL] [Abstract][Full Text] [Related]
16. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance]. Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024 [TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma. Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; He ZW; Zeng JX; Zhang CF Mol Med Rep; 2017 Feb; 15(2):605-612. PubMed ID: 28000881 [TBL] [Abstract][Full Text] [Related]
18. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma. Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281 [TBL] [Abstract][Full Text] [Related]
19. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis. Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis. Li M; He XY; Zhang ZM; Li S; Ren LH; Cao RS; Feng YD; Ji YL; Zhao Y; Shi RH World J Gastroenterol; 2015 Mar; 21(11):3245-55. PubMed ID: 25805931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]